What is your approach in a transplant-eligible patient with relapsed classical Hodgkin lymphoma who has an area of refractory disease after salvage chemotherapy?   

Would you still proceed to high-dose therapy and autologous SCT?

Would you incorporate radiation pre- or post- transplant? Or offer additional salvage systemic therapy prior to auto SCT?



Answer from: Medical Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice

Answer from: Medical Oncologist at Community Practice